[ad_1]
Medidata, a Dassault Systèmes company, will be sharing insights into new decentralized clinical trials (DCTs) and AI technologies as a signature sponsor of the annual Summit for Clinical Ops Executives (SCOPE), February 7-10. Medidata experts will be participating in multiple presentations covering a range of innovative solutions to advance clinical trial planning, management, and operations.
“Our industry has been driven, and in many ways pushed, to innovate over the past two years. SCOPE is a great opportunity for us to share our insights about where clinical trials are headed, and to join conversations with our peers as we work together to serve patients,” said Jackie Kent, chief customer officer at Medidata. “In addition to our presentations and panels at SCOPE, we are proud to be part of the judging panel selecting the 2022 Participant Engagement Award winner, an honor afforded to us as the winner in 2021.”
Presentations:
Building an End-to-end Study Planning and Execution Predictive Platform – A Collaboration Between PPD and Medidata Acorn AI
– Fareed Melhem, SVP, Medidata Acorn AI and John Van Hoy, Executive Director, Data Science & Advanced Analytics, PPD, part of Thermo Fisher Scientific
As biopharma companies require better site feasibility and forecasting to manage their clinical studies, Medidata Acorn AI and PPD have collaborated to build predictive models and technology combined with data to enhance these efforts and deliver real-time trial management.
Faster, Smarter, Safer: Three Clinical Data Management Practices for the New …
Full story available on Benzinga.com
[ad_2]
Source link
